Company Filing History:
Years Active: 1998
Title: Innovations by Mark T Satter
Introduction
Mark T Satter is a notable inventor based in Kenosha, WI (US). He has made significant contributions to the field of biotechnology, particularly in the production of high-purity antibiotics. With a total of 2 patents, his work showcases the intersection of innovation and advanced genetic engineering.
Latest Patents
Satter's latest patents focus on the production of high purity 6,12-dideoxyerythromycin A. This process utilizes recombinant DNA technology to enhance the efficiency of antibiotic production. The erythromycin-producing strain, Saccharopolyspora erythraea, is engineered to lack specific hydroxylases, resulting in a mixture of 6,12-dideoxyerythromycin A and its precursor, 6-deoxyerythromycin D. By inserting a second copy of the eryG gene into a non-essential region of the Sac. erythraea chromosome, Satter's method achieves high purity levels of the final product.
Career Highlights
Mark T Satter is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in pharmaceutical production.
Collaborations
Throughout his career, Satter has collaborated with notable colleagues, including Diane L Stassi and Gregory Thomas Maine. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in biotechnology.
Conclusion
Mark T Satter's contributions to the field of biotechnology, particularly in antibiotic production, highlight his role as an influential inventor. His innovative approaches continue to impact the healthcare industry positively.